Literature DB >> 31381872

Protein-protein interactions of drug uptake transporters that are important for liver and kidney.

Yuchen Zhang1, Bruno Hagenbuch2.   

Abstract

Drug uptake transporters are membrane proteins responsible for the trans-membrane transport of endo- and xenobiotics, including numerous drugs. They are important for the uptake of drugs into target tissues or into organs for metabolism and excretion. Many drug uptake transporters have a broad spectrum of structural-independent substrates, which make them vulnerable to drug-drug interactions. Recent studies have shown more and more complex pharmacokinetics involving transporters, and regulatory agencies now require studies to be performed to measure the involvement of transporters in drug development. A better understanding of the factors affecting the expression of transporters is needed. Despite many efforts devoted to the functional characterization of different drug uptake transporters, transporter in vitro to in vivo extrapolations are far from predicting the behavior under physiological conditions. There is an increasing number of uptake transporters demonstrated to form protein-protein interactions or to oligomerize. This raises the possibility that these interactions between or among transporters could help explaining the gap between in vitro and in vivo measurement of drug transporters. In this review, we summarized protein-protein interactions of drug uptake transporters that are important for pharmacokinetics, especially those in the liver and the kidneys.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug transporter; Hepatocyte; OATP; Protein-protein interactions

Year:  2019        PMID: 31381872      PMCID: PMC6733649          DOI: 10.1016/j.bcp.2019.07.026

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  73 in total

Review 1.  Regulation of G protein-coupled receptor signaling by scaffold proteins.

Authors:  Randy A Hall; Robert J Lefkowitz
Journal:  Circ Res       Date:  2002-10-18       Impact factor: 17.367

Review 2.  Protein oligomerization: how and why.

Authors:  Mayssam H Ali; Barbara Imperiali
Journal:  Bioorg Med Chem       Date:  2005-09-01       Impact factor: 3.641

3.  Human organic anion transporter hOAT1 forms homooligomers.

Authors:  Mei Hong; Wen Xu; Takeshi Yoshida; Kunihiko Tanaka; Donald J Wolff; Fanfan Zhou; Masayori Inouye; Guofeng You
Journal:  J Biol Chem       Date:  2005-07-26       Impact factor: 5.157

4.  Interaction with PDZK1 is required for expression of organic anion transporting protein 1A1 on the hepatocyte surface.

Authors:  Pijun Wang; Jin J Wang; Yansen Xiao; John W Murray; Phyllis M Novikoff; Ruth Hogue Angeletti; George A Orr; Debin Lan; David L Silver; Allan W Wolkoff
Journal:  J Biol Chem       Date:  2005-06-30       Impact factor: 5.157

5.  Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.

Authors:  George K Dresser; David G Bailey; Brenda F Leake; Ute I Schwarz; Paul A Dawson; David J Freeman; Richard B Kim
Journal:  Clin Pharmacol Ther       Date:  2002-01       Impact factor: 6.875

6.  The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter.

Authors:  Paul A Dawson; Melissa Hubbert; Jamie Haywood; Ann L Craddock; Noa Zerangue; Whitney V Christian; Nazzareno Ballatori
Journal:  J Biol Chem       Date:  2004-11-24       Impact factor: 5.157

7.  Protein-protein interactions and membrane localization of the human organic solute transporter.

Authors:  An-Qiang Sun; Natarajan Balasubramaniyan; Ke Xu; Chuan Ju Liu; Vijaya M Ponamgi; Hongguang Liu; Frederick J Suchy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-03-01       Impact factor: 4.052

Review 8.  Molecular basis for glucose-galactose malabsorption.

Authors:  Ernest M Wright; Eric Turk; Martin G Martin
Journal:  Cell Biochem Biophys       Date:  2002       Impact factor: 2.194

9.  Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition.

Authors:  Marija Ljubojevic; Carol M Herak-Kramberger; Yohannes Hagos; Andrew Bahn; Hitoshi Endou; Gerhard Burckhardt; Ivan Sabolic
Journal:  Am J Physiol Renal Physiol       Date:  2004-03-09

10.  The novel putative bile acid transporter SLC10A5 is highly expressed in liver and kidney.

Authors:  Carla F Fernandes; José R Godoy; Barbara Döring; Marcia C O Cavalcanti; Martin Bergmann; Ernst Petzinger; Joachim Geyer
Journal:  Biochem Biophys Res Commun       Date:  2007-07-10       Impact factor: 3.575

View more
  3 in total

Review 1.  Post-translational regulation of the major drug transporters in the families of organic anion transporters and organic anion-transporting polypeptides.

Authors:  Wooin Lee; Jeong-Min Ha; Yuichi Sugiyama
Journal:  J Biol Chem       Date:  2020-10-13       Impact factor: 5.157

2.  IID 2021: towards context-specific protein interaction analyses by increased coverage, enhanced annotation and enrichment analysis.

Authors:  Max Kotlyar; Chiara Pastrello; Zuhaib Ahmed; Justin Chee; Zofia Varyova; Igor Jurisica
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

3.  Determination of the Dissolution/Permeation and Apparent Solubility for Microencapsulated Emamectin Benzoate Using In Vitro and Ex Vivo Salmo salar Intestine Membranes.

Authors:  Victoria Molina; Carlos von Plessing; Alex Romero; Sergio Benavides; José Miguel Troncoso; José Ricardo Pérez-Correa; Wendy Franco
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.